<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Turner MS</submitter><funding>NCI NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>4895-903</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3142864</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>183(8)</volume><pubmed_abstract>The definitions of tolerogenic vs immunogenic dendritic cells (DC) remain controversial. Immature DC have been shown to induce T regulatory cells (Treg) specific for foreign and allogeneic Ags. However, we have previously reported that mature DC (mDC) prevented the onset of autoimmune diabetes, whereas immature DC (iDC) were therapeutically ineffective. In this study, islet-specific CD4(+) T cells from BDC2.5 TCR-transgenic mice were stimulated in the absence of exogenous cytokine with iDC or mDC pulsed with high- or low-affinity antigenic peptides and examined for Treg induction. Both iDC and mDC presenting low peptide doses induced weak TCR signaling via the Akt/mammalian target of rapamycin (mTOR) pathway, resulting in significant expansion of Foxp3(+) Treg. Furthermore, unpulsed mDC, b</pubmed_abstract><journal>Journal of immunology (Baltimore, Md. : 1950)</journal><pubmed_title>Dominant role of antigen dose in CD4+Foxp3+ regulatory T cell induction and expansion.</pubmed_title><pmcid>PMC3142864</pmcid><funding_grant_id>R01 GM080398</funding_grant_id><funding_grant_id>T32 CA082084-10</funding_grant_id><funding_grant_id>R01 GM080398-03</funding_grant_id><funding_grant_id>R01 GM080398-02</funding_grant_id><funding_grant_id>T32 CA082084</funding_grant_id><funding_grant_id>5T32CA82084-10</funding_grant_id><pubmed_authors>Turner MS</pubmed_authors><pubmed_authors>Kane LP</pubmed_authors><pubmed_authors>Morel PA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Dominant role of antigen dose in CD4+Foxp3+ regulatory T cell induction and expansion.</name><description>The definitions of tolerogenic vs immunogenic dendritic cells (DC) remain controversial. Immature DC have been shown to induce T regulatory cells (Treg) specific for foreign and allogeneic Ags. However, we have previously reported that mature DC (mDC) prevented the onset of autoimmune diabetes, whereas immature DC (iDC) were therapeutically ineffective. In this study, islet-specific CD4(+) T cells from BDC2.5 TCR-transgenic mice were stimulated in the absence of exogenous cytokine with iDC or mDC pulsed with high- or low-affinity antigenic peptides and examined for Treg induction. Both iDC and mDC presenting low peptide doses induced weak TCR signaling via the Akt/mammalian target of rapamycin (mTOR) pathway, resulting in significant expansion of Foxp3(+) Treg. Furthermore, unpulsed mDC, b</description><dates><release>2009-01-01T00:00:00Z</release><publication>2009 Oct</publication><modification>2025-04-04T12:00:40.444Z</modification><creation>2019-03-26T23:42:54Z</creation></dates><accession>S-EPMC3142864</accession><cross_references><pubmed>19801514</pubmed><doi>10.4049/jimmunol.0901459</doi></cross_references></HashMap>